Also trades as: EXE.TO (TSX) · $vol 10M · 0S9E.L (LSE) · $vol 0M

$19.93

-1.05 (-5.00%)

Weekly Expected Move ±13.8%

$14 $17 $20 $23 $25

OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 43 · $1.9B mcap · 94M float · 0.097% daily turnover · Short 49% of daily vol

Revenue

$1.7B +13.2% ▲

5Y CAGR: +7.5%

Gross Profit

$199M -86.4% ▼

5Y CAGR: +0.2%

Operating Income

$138M +24.3% ▲

5Y CAGR: +8.2%

Net Income

$97M +28.4% ▲

5Y CAGR: +12.3%

EPS (Diluted)

$1.11 +29.1% ▲

5Y CAGR: +13.1%

EBITDA

$175M +13.0% ▲

5Y CAGR: +6.7%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.2B	$1.2B	$1.3B	$1.5B	$1.7B
YoY Growth	+0.8%	+4.7%	+6.8%	+12.4%	+13.2%
Cost of Revenue	$1.1B	$1.1B	$1.1B	$0	$1.5B
Gross Profit	$116M	$77M	$168M	$1.5B	$199M
Gross Margin	9.9%	6.3%	12.8%	100.0%	12.0%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$52M	$1.2B	$56M	$1.2B	$61M
Operating Expenses	$52M	$1.2B	$1.2B	$1.4B	$61M
Operating Income	$63M	$21M	$112M	$111M	$138M
Operating Margin	5.4%	1.7%	8.6%	7.6%	8.3%
Interest Expense	$23M	$21M	$22M	$22M	$19M
Income Before Tax	$14M	-$4M	$45M	$100M	$130M
Tax Expense	$6M	$15K	$11M	$25M	$33M
Net Income	$12M	$70M	$34M	$75M	$97M
Net Margin	1.0%	5.7%	2.6%	5.1%	5.8%
EPS (Diluted)	$0.11	$-0.05	$0.40	$0.86	$1.11
EBITDA	$75M	$49M	$99M	$155M	$175M
Shares Outstanding	90M	89M	85M	95M	87M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$359M	$392M	$375M	$383M	$440M	$462M	$466M	$611M
Cost of Revenue	$0	$0	$0	$0	$0	$406M	$407M	$541M
Gross Profit	$359M	$392M	$375M	$383M	$440M	$55M	$59M	$70M
Gross Margin	100.0%	100.0%	100.0%	100.0%	100.0%	12.0%	12.7%	11.5%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$294M	$316M	$310M	$317M	$357M	$16M	$379M	$18M
Operating Expenses	$332M	$360M	$347M	$352M	$399M	$16M	$16M	$18M
Operating Income	$27M	$31M	$27M	$31M	$41M	$39M	$43M	$52M
Operating Margin	7.7%	8.0%	7.3%	8.2%	9.3%	8.5%	9.2%	8.6%
Interest Expense	$5M	$6M	$5M	$4M	$5M	$5M	$5M	$17M
Income Before Tax	$23M	$27M	$19M	$41M	$34M	$35M	$49M	$38M
Tax Expense	$6M	$7M	$4M	$9M	$10M	$10M	$9M	$7M
Net Income	$16M	$20M	$15M	$32M	$24M	$26M	$41M	$31M
Net Margin	4.5%	5.1%	4.0%	8.3%	5.5%	5.5%	8.8%	5.0%
EPS (Diluted)	$0.19	$0.28	$0.18	$0.37	$0.28	$0.29	$0.42	$0.31
EBITDA	$37M	$41M	$32M	$54M	$49M	$49M	$53M	$68M
Shares Outstanding	86M	95M	85M	86M	86M	89M	97M	97M

EXETF OTC